Trivant Custom Portfolio Group »

Travere Therapeutics shares owned by Trivant Custom Portfolio Group

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Trivant Custom Portfolio Group from 13F filings

Historical chart of Trivant Custom Portfolio Group investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Trivant Custom Portfolio Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Trivant Custom Portfolio Group

Quarter filed Position value Share count Share price at filing
2023-09-30 $5.1k 575 8.94
2023-06-30 $8.8k 575 15.36
2023-03-31 $13k 575 22.49

More positions owned by Trivant Custom Portfolio Group

Apple Aapl (AAPL)
Microsoft Corp MSFT (MSFT)
Nvidia Corp Nvda (NVDA)
Flexshares Disciplined Durtn Mbs Etf MBSD (MBSD)
Amazon.com Amzn (AMZN)
Alphabet Inc. Class A Googl (GOOGL)
Advanced Micro Device In Amd (AMD)
Merck & Co MRK (MRK)
Ishares 0-5 Year Tips Bond Etf Stip (STIP)
Deere & Co De (DE)
Costco Wholesale Cost (COST)
Ishares Brd Usd Inv Grd Corp Bd Etf Usig (USIG)
Northrop Grumman Noc (NOC)
General Electric Co Trades With Due Bills Ge (GE)
Lowes Companies Low (LOW)

View all positions for Trivant Custom Portfolio Group

Top funds holding Travere Therapeutics

Vanguard Group
Deutsche Bank Aktiengesellschaft
Kynam Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of America Corporation
Goldman Sachs Group
Millennium Management
Emerald Advisers
Avidity Partners Management
Emerald Mutual Fund Advisers, Trust
Schonfeld Strategic Advisors
Barclays
Healthcare Of Ontario Pension Plan Trust Fund
Two Sigma Advisers

View all funds holding Travere Therapeutics